CRL logo

CRL Working Capital

CRL Annual Working Capital

$553.58 M
+$206.13 M+59.33%

30 December 2023

CRL Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRL Quarterly Working Capital

$482.50 M
-$69.25 M-12.55%

28 September 2024

CRL Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRL Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+59.3%-12.8%
3 y3 years+53.2%-12.8%
5 y5 years+63.0%-12.8%

CRL Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+129.8%-32.4%+100.3%
5 y5-yearat high+129.8%-32.4%+100.3%
alltimeall timeat high+1832.1%-32.4%+1632.3%

Charles River Laboratories International Working Capital History

DateAnnualQuarterly
Sept 2024
-
$482.50 M(-12.6%)
June 2024
-
$551.75 M(-22.7%)
Mar 2024
-
$713.38 M(+28.9%)
Dec 2023
$553.58 M(+59.3%)
$553.58 M(+22.9%)
Sept 2023
-
$450.51 M(-9.4%)
June 2023
-
$497.16 M(+6.5%)
Mar 2023
-
$466.96 M(+34.4%)
Dec 2022
$347.45 M(+44.2%)
$347.45 M(-13.4%)
Sept 2022
-
$401.16 M(+16.3%)
June 2022
-
$344.95 M(+1.7%)
Mar 2022
-
$339.25 M(+40.8%)
Dec 2021
$240.91 M(-33.3%)
$240.91 M(-39.1%)
Sept 2021
-
$395.29 M(+16.8%)
June 2021
-
$338.30 M(-45.4%)
Mar 2021
-
$619.83 M(+71.5%)
Dec 2020
$361.38 M(+16.1%)
$361.38 M(+2.3%)
Sept 2020
-
$353.26 M(-30.3%)
June 2020
-
$506.79 M(-2.0%)
Mar 2020
-
$517.38 M(+66.3%)
Dec 2019
$311.14 M(-8.4%)
$311.14 M(+7.0%)
Sept 2019
-
$290.76 M(-22.4%)
June 2019
-
$374.46 M(+11.3%)
Mar 2019
-
$336.42 M(-0.9%)
Dec 2018
$339.61 M(-6.5%)
$339.61 M(+13.7%)
Sept 2018
-
$298.57 M(-19.6%)
June 2018
-
$371.39 M(-14.9%)
Mar 2018
-
$436.25 M(+20.1%)
Dec 2017
$363.12 M(+59.8%)
$363.12 M(-1.0%)
Sept 2017
-
$366.62 M(+16.8%)
June 2017
-
$314.00 M(-0.9%)
Mar 2017
-
$316.75 M(+39.4%)
Dec 2016
$227.24 M(-8.2%)
$227.24 M(-6.3%)
Sept 2016
-
$242.53 M(-15.8%)
June 2016
-
$288.15 M(-12.0%)
Mar 2016
-
$327.40 M(+32.3%)
Dec 2015
$247.47 M(-13.0%)
$247.47 M(-6.5%)
Sept 2015
-
$264.56 M(-25.1%)
June 2015
-
$353.12 M(+2.8%)
Mar 2015
-
$343.65 M(+20.8%)
Dec 2014
$284.57 M(-6.9%)
$284.57 M(-11.9%)
Sept 2014
-
$322.94 M(+0.6%)
June 2014
-
$321.05 M(-8.6%)
Mar 2014
-
$351.34 M(+15.0%)
Dec 2013
$305.52 M(+113.6%)
$305.52 M(-2.3%)
Sept 2013
-
$312.61 M(+6.4%)
June 2013
-
$293.90 M(+81.6%)
Mar 2013
-
$161.81 M(+13.1%)
Dec 2012
$143.00 M
$143.00 M(+7.8%)
Sept 2012
-
$132.68 M(+7.5%)
June 2012
-
$123.43 M(-42.2%)
DateAnnualQuarterly
Mar 2012
-
$213.44 M(+2.1%)
Dec 2011
$209.05 M(-28.7%)
$209.05 M(-10.1%)
Sept 2011
-
$232.49 M(-14.3%)
June 2011
-
$271.15 M(+7.3%)
Mar 2011
-
$252.78 M(-13.8%)
Dec 2010
$293.11 M(-15.2%)
$293.11 M(+1.1%)
Sept 2010
-
$289.92 M(-19.9%)
June 2010
-
$361.99 M(-1.2%)
Mar 2010
-
$366.52 M(+6.0%)
Dec 2009
$345.83 M(+9.0%)
$345.83 M(+10.7%)
Sept 2009
-
$312.26 M(+4.1%)
June 2009
-
$300.06 M(-0.6%)
Mar 2009
-
$301.85 M(-4.8%)
Dec 2008
$317.14 M(+3.9%)
$317.14 M(+198.3%)
Sept 2008
-
$106.31 M(-39.7%)
June 2008
-
$176.16 M(-48.7%)
Mar 2008
-
$343.25 M(+12.4%)
Dec 2007
$305.34 M(+26.3%)
$305.34 M(+15.2%)
Sept 2007
-
$264.98 M(+2.8%)
June 2007
-
$257.87 M(+9.3%)
Mar 2007
-
$235.95 M(-2.4%)
Dec 2006
$241.76 M(+124.0%)
$241.76 M(-21.0%)
Sept 2006
-
$306.15 M(+21.8%)
June 2006
-
$251.26 M(+73.7%)
Mar 2006
-
$144.64 M(+34.0%)
Dec 2005
$107.91 M(-33.1%)
$107.91 M(-40.2%)
Sept 2005
-
$180.52 M(+10.7%)
June 2005
-
$163.06 M(-17.3%)
Mar 2005
-
$197.23 M(+22.4%)
Dec 2004
$161.19 M(-37.2%)
$161.19 M(-51.0%)
Sept 2004
-
$329.29 M(+8.9%)
June 2004
-
$302.25 M(+9.6%)
Mar 2004
-
$275.65 M(+7.5%)
Dec 2003
$256.54 M(+55.7%)
$256.54 M(+8.9%)
Sept 2003
-
$235.53 M(+11.2%)
June 2003
-
$211.80 M(+16.0%)
Mar 2003
-
$182.53 M(+10.8%)
Dec 2002
$164.72 M(+47.6%)
$164.72 M(-4.8%)
Sept 2002
-
$173.02 M(+26.0%)
June 2002
-
$137.33 M(-32.8%)
Mar 2002
-
$204.44 M(+83.2%)
Dec 2001
$111.62 M(+101.4%)
$111.62 M(-19.1%)
Sept 2001
-
$137.96 M(+69.9%)
June 2001
-
$81.19 M(-15.3%)
Mar 2001
-
$95.90 M(+73.1%)
Dec 2000
$55.42 M(+93.4%)
$55.42 M(+3.2%)
Sept 2000
-
$53.72 M(+30.2%)
June 2000
-
$41.26 M(+48.1%)
Mar 2000
-
$27.85 M
Dec 1999
$28.65 M(-17.7%)
-
Dec 1998
$34.83 M
-

FAQ

  • What is Charles River Laboratories International annual working capital?
  • What is the all time high annual working capital for Charles River Laboratories International?
  • What is Charles River Laboratories International annual working capital year-on-year change?
  • What is Charles River Laboratories International quarterly working capital?
  • What is the all time high quarterly working capital for Charles River Laboratories International?
  • What is Charles River Laboratories International quarterly working capital year-on-year change?

What is Charles River Laboratories International annual working capital?

The current annual working capital of CRL is $553.58 M

What is the all time high annual working capital for Charles River Laboratories International?

Charles River Laboratories International all-time high annual working capital is $553.58 M

What is Charles River Laboratories International annual working capital year-on-year change?

Over the past year, CRL annual working capital has changed by +$206.13 M (+59.33%)

What is Charles River Laboratories International quarterly working capital?

The current quarterly working capital of CRL is $482.50 M

What is the all time high quarterly working capital for Charles River Laboratories International?

Charles River Laboratories International all-time high quarterly working capital is $713.38 M

What is Charles River Laboratories International quarterly working capital year-on-year change?

Over the past year, CRL quarterly working capital has changed by -$71.08 M (-12.84%)